
Join to View Full Profile
310 Cedar StreetDepartment Of Pathology, Yale UniversityNew Haven, CT 06520
Phone+1 203-785-2757
Dr. Katz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women’s Hospital/Massachusetts General HospitalFellowship, Hematopathology, 2006 - 2007
- Mass General Brigham/Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2004 - 2006
- Harvard Medical SchoolClass of 2004
Certifications & Licensure
- CT State Medical License 2012 - 2025
- OH State Medical License 2014 - 2021
- IL State Medical License 2014 - 2020
- AL State Medical License 2014 - 2019
- AR State Medical License 2014 - 2019
- IN State Medical License 2014 - 2019
- MA State Medical License 2008 - 2019
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Hematopathology
- Join now to see all
Publications & Presentations
PubMed
- Tumor-Specific Antigen Delivery for T-cell Therapy via a pH-Sensitive Peptide Conjugate.Annali M Yurkevicz, Yanfeng Liu, Samuel G Katz, Peter M Glazer
Molecular Cancer Therapeutics. 2025-01-02 - Alternative transcripts recode human genes to express overlapping, frameshifted microproteins.Haomiao Su, Samuel G Katz, Sarah A Slavoff
Biorxiv. 2024-10-25 - Finding Your CAR: The Road Ahead for Engineered T Cells.Po-Han Chen, Rianna Raghunandan, Jon S Morrow, Samuel G Katz
The American Journal of Pathology. 2024-08-01
Press Mentions
- CAR T-cell Therapy: Pathology Is Key to This Revolutionary Cancer TreatmentOctober 7th, 2024
- Spatial Transcriptomics Puts More Biology on the MapSeptember 1st, 2021
Grant Support
- Cell Death Regulation by Pro-Apoptotic BOK in TauopathiesYALE UNIVERSITY2024–2027
- Cell Death Regulation by Pro-Apoptotic BOK in TauopathiesYALE UNIVERSITY2024–2027
- Cell Death Regulation by Pro-Apoptotic BOK in TauopathiesYALE UNIVERSITY2024–2027
- Cell Death Regulation by Pro-Apoptotic BOK in TauopathiesYALE UNIVERSITY2024–2027
- Cell Death Regulation by Pro-Apoptotic BOK in TauopathiesYALE UNIVERSITY2024–2027
- Contribution of Mitochondrial Associated Membrane (MAM) Signaling to NeurodegenerationYALE UNIVERSITY2024–2026
- Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell ReprogrammingYALE UNIVERSITY2023–2025
- Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell ReprogrammingYALE UNIVERSITY2023–2025
- Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell ReprogrammingYALE UNIVERSITY2023–2025
- Enhancing Melanoma TIL Efficacy with Multifactor mRNA-Mediated T Cell ReprogrammingYALE UNIVERSITY2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: